United Therapeutics Corporation
UTHR
$556.82
-$5.27-0.94%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.15B | 2.92B | 2.77B | 3.05B | 3.32B |
| Total Receivables | 312.00M | 350.20M | 297.70M | 379.30M | 322.00M |
| Inventory | 178.30M | 183.10M | 176.50M | 169.20M | 165.40M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 228.00M | 248.90M | 252.20M | 229.70M | 131.10M |
| Total Current Assets | 2.87B | 3.70B | 3.49B | 3.83B | 3.94B |
|
|
|||||
| Total Current Assets | 2.87B | 3.70B | 3.49B | 3.83B | 3.94B |
| Net Property, Plant & Equipment | 1.84B | 1.73B | 1.56B | 1.36B | 1.30B |
| Long-term Investments | -- | 32.30M | -- | -- | -- |
| Goodwill | -- | 32.30M | -- | -- | -- |
| Total Other Intangibles | 115.50M | 84.20M | 116.70M | 111.50M | 111.70M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 477.00M | 500.80M | 528.50M | 630.50M | 620.00M |
| Total Assets | 6.71B | 7.88B | 7.35B | 7.91B | 7.74B |
|
|
|||||
| Total Accounts Payable | 498.30M | 7.10M | 468.00M | 432.00M | 367.00M |
| Total Accrued Expenses | -- | 506.90M | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 7.30M | -- | -- | 200.00M |
| Total Finance Division Other Current Liabilities | 100.80M | 39.30M | 78.30M | 95.10M | 154.50M |
| Total Other Current Liabilities | 100.80M | 39.30M | 78.30M | 95.10M | 154.50M |
| Total Current Liabilities | 599.10M | 560.60M | 546.30M | 527.10M | 721.50M |
|
|
|||||
| Total Current Liabilities | 599.10M | 560.60M | 546.30M | 527.10M | 721.50M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 30.30M | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 214.00M | 192.90M | 214.60M | 207.30M | 215.20M |
| Total Liabilities | 813.10M | 783.80M | 760.90M | 734.40M | 936.70M |
|
|
|||||
| Common Stock & APIC | 2.52B | 2.80B | 2.66B | 2.79B | 2.74B |
| Retained Earnings | 8.83B | 8.56B | 8.19B | 7.85B | 7.54B |
| Treasury Stock & Other | -5.45B | -4.26B | -4.26B | -3.47B | -3.48B |
| Total Common Equity | 5.90B | 7.10B | 6.59B | 7.17B | 6.81B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.90B | 7.10B | 6.59B | 7.17B | 6.81B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.90B | 7.10B | 6.59B | 7.17B | 6.81B |
|
|
|||||